FDA WARNING_LETTER - Curativa Bay Corporation - June 22, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On June 25, 2020, the FDA and FTC issued a Warning Letter to Curativa Bay regarding their "Advanced Hypochlorous Skin Spray" product. The agencies reviewed the company's websites, https://www.curativabay.com and www.facebook.com/curativabay, on June 16 and June 22, 2020, respectively.
The FDA determined that the product is an unapproved new drug under section 505(a) of the FD&C Act (21 U.S.C. § 355(a)) and a misbranded drug under section 502 (21 U.S.C. § 352). The product is marketed with claims to mitigate, prevent, treat, diagnose, or cure COVID-19, which are unsubstantiated. The introduction of such products into interstate commerce is prohibited by sections 301(a) and (d) of the FD&C Act (21 U.S.C. § 331(a) and (d)).
The FTC stated that advertising a product to prevent, treat, or cure human disease requires competent and reliable scientific evidence, including well-controlled human clinical studies, which are not known to exist for this product regarding COVID-19.
Curativa Bay must immediately cease the sale of these unapproved and unauthorized products. Within 4
ID · bf3e5b6b-97bb-471e-a648-761bd5a1bc3d
Full citation text and observation details available on the Dashboard.